InvestorsHub Logo
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

Re: None

Tuesday, 10/13/2020 2:05:35 AM

Tuesday, October 13, 2020 2:05:35 AM

Post# of 185
$RLFTF (Covid-19) NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100™ (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to


https://relieftherapeutics.com/neurorx-and-relief-announce-topline-efficacy-data-from-patients-treated-with-rlf-100-aviptadil-under-the-u-s-fda-expanded-access-protocol-authorization-for-respiratory-failure-related-to/

~ Money Making Money ~

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.